Related Experiment Video
Updated: Jul 3, 2026

08:18
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres
1Institute of Pharmacy, Pt Ravishankar Shukla University, Raipur, India.
Journal of Microencapsulation
|August 8, 2008
Summary
This study developed an oral sustained release system for Serratiopeptidase using Eudragit S100 microspheres. Formulation optimization achieved high drug encapsulation and controlled enzyme release, offering an economical approach.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
Background:
- Serratiopeptidase is an acid-labile enzyme requiring protection for oral delivery.
- Developing sustained-release microparticulate systems is crucial for improving oral bioavailability of such enzymes.
Purpose of the Study:
- To develop an oral sustained release microparticulate system for Serratiopeptidase.
- To optimize Eudragit S100 microspheres using a 3(2) full factorial design.
- To investigate the impact of formulation variables on microsphere characteristics and enzyme activity.
Main Methods:
- Modified double emulsion solvent evaporation technique for microsphere preparation.
- 3(2) full factorial design to study external aqueous phase volume and Tween 80 concentration.
- Scanning electron microscopy (SEM) for particle morphology analysis.
- In vitro proteolytic activity assay to confirm enzyme integrity and release kinetics.
Main Results:
- External aqueous phase volume significantly affected entrapment efficiency; Tween 80 concentration significantly impacted microsphere size.
- Optimized microspheres exhibited smooth spherical morphology with high drug encapsulation (81.32 ± 3.97%).
- Controlled enzyme release observed: minimal release at pH 1.2 and sustained release in phosphate buffer, following Higuchi kinetics (R(2) = 0.987).
Conclusions:
- The study successfully developed an optimized Eudragit S100 microparticulate system for oral sustained release of Serratiopeptidase.
- The formulation optimization using factorial design proved economical and efficient.
- The developed system ensures enzyme stability and controlled release, enhancing therapeutic potential.

